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uideline. The strains were also typed by random ampliﬁed poly-
orphic DNA (RAPD). The lipid A from resistance strains were
xtracted and subjected to the analysis using MALDI-TOF mass
pectrometry.
Results: Sensitivity to colistin were determined when the MIC
s ≤ 2 g/ml according to CLSI guideline. Of the two hundred
trains collected, twenty were found to have MIC ranging from 4
o 128 g/ml. The RAPD grouped the resistance strains into ﬁve
roups. The MALDI-TOF MS revealed that the basic structure of A.
uamannii lipid A is the heptaacylated diphosphoryl lipid A (m/z
910). The resistance strains exhibited the extra peaks at either
/z 2034, 2071 or 2194, which correspond to the additions of
hosphoethanolamine, hexosamine or both to lipid A molecule,
espectively. The addition of these residues takes place at the phos-
hate moieties of lipid A thus potentially cancelling the negative
harges and may render A. baumannii the resistance to colistin.
Conclusion: The analysis of lipid A from Thai A. baumannii col-
stin resistance strains demonstrates themodiﬁcation bywhich the
egative charges were eliminated by the addition of small residues
nd may subsequently lead to the reduction of colistin target.
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aboratory and Research, Kathmandu, Nepal
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Background: International clones ofmulti-drug resistantAcine-
obacter baumannii integrated with Genomic Resistance Islands
GRI); AbaR1, AbaR2, AbaR3, AbaR5havebeen identiﬁed. Theobjec-
ive of this study was to identify GRI harboring A. baumannii in
hailand and to establish its genetic linkage with international
lones.
Methods: Thirty seven non-repetitive clinical isolates of
arbapenem resistant A. baumannii were studied. Dot blot
ybridizationwas performed to screen for class 1 integron element
ntegrase gene (IntI1). Cassette characterization of class 1 integron
lement, GRI junctional typing, and ampliﬁcation of class 1 inte-
ron borne resistance genes were performed by PCR. Real time
ultiplex-PCR (RT-MPCR) was performed to amplify integron and
on-integron borne genes present in GRIs and resistant plasmid;
baR1, AbaR2, AbaR3, AbaR5, and plasmid pACICU. Clonal evalua-
ion was carried out by Multi-locus Sequence Typing (MLST) and
Burst analysis.
Results: Four GRI junctional typeswere identiﬁed, type I (n =24,
oth5′ and3′ junctionspresent), type II (n =3, 5′ junctiononly), type
II (n =7, 3′ junction only), and type IV (n=3, no junction identiﬁed).
heprevalenceof class1 integronelementwas81.08%and this inte-
ron element harbored blaVEB-1 (n=7), arr-2 (n =10), cmlA (n =5),
la0XA-10 (n=9), and blaTEM-1 (n=15) genes. Cassette organiza-
ion in blaVEB-1 containing 5.5 kb class 1 integron element was
′CS-aadB-blaVEB-1-arr-2-cmlA-aadA1-blaOXA-10-3′CS. RT-MPCR
dentiﬁed a presence of arsC (n =32), aacA4 (n =23), aac3 (n =15),fectious Diseases 16S (2012) e317–e473
and pACICU (n=9). MLST typed 9 isolates into 6 STs; ST88 (n=1),
ST119 (n=3), ST198-202 (one each). The isolates with similar junc-
tional types had unique STs. The eBurst analysis for the ﬁrst time
identiﬁed the presence of pan-European clone I and II and Chinese
clone ZS4 in Thailand.
Conclusion: The international clones of A. baumannii integrated
with variants of GRI were prevalent in Thailand. Monitoring and
surveillance of these multi-drug resistance clones is necessary to
prevent further spread of these international multi-drug resistant
clones in Thailand.
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Willey3, H. Didier4, L. Mataseje5, M. McCracken5, D. Boyd5,
M.R. Mulvey5, T. Mazzulli 4
1 THE UNIVERSITY OF THE WEST INDIES, Kingston, Jamaica
2 University of the West Indies, Kingston, Jamaica
3 The Mount Sinai Hosptal, Toronto, ON, Canada
4 The Mount Sinai Hospital, Toronto, ON, Canada
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Background: Resistance of clinically signiﬁcant bacteria to car-
bapenem antibiotics, through the production of carbapenemases
has becomeaglobal problem. This has serious implications as infec-
tions caused by these resistant organisms are difﬁcult to manage.
Our aims were to determine if carbapenemases were a mech-
anism of resistance among MDRGNB isolated at the Microbiology
Laboratory, UniversityHospital of theWest Indies (UHWI), Jamaica,
to identify speciﬁc carbapenemase genes and to determine the
relatedness of the strains, so that policies regarding infection con-
trol and antibiotic therapy could be better informed.
Methods:AtUHWI fromMay2009 toMarch2011, 105MDRGNB
(1Klebsiella pneumoniae, 3 Escherichia coli, 82 Acinetobacter spp. and
19 Pseudomonas spp.) were identiﬁed as potential carbapenemase
producers during routine susceptibility testing of clinical isolates.
Further phenotypic screening for carbapenemase production was
performed using inhibitors and the modiﬁed Hodge test. Multi-
plex PCR for identifying OXA-23, 24, 51, 58 was performed on
Acinetobacter spp. For the remaining isolates, multiplex PCRwas
performed to detectNDM, KPC, VIM, GES, IMP and OXA-48 car-
bapenemase genes. PFGE was used to determine the relatedness
of carbapenemase-positive isolates.
Results: Of 4 Enterobacteriacae tested, phenotypic screening
and PCR identiﬁed the Klebsiella pneumoniae as the ﬁrst isolate in
Jamaica to possess the NDM-1 gene. Of the 82 Acinetobacter spp., all
but 1 were positive for blaOXA 51, 12 had blaOXA 24, 2 blaOXA23,
and 1 blaOXA58. One P. aeruginosahad the GES gene, but without
sequencing, its carbapenemase activity is uncertain. Acinetobacter
spp. and Pseudomonas spp. sharing similar genotypes were highly
related, suggesting an endemic or outbreak strain.
Conclusion: Carbapenemase production is a cause of resistance
amongst MDRGNB in Jamaica, some of which are related. Pheno-
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organism, an aggressive infection control strategy should early be
established.
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ypic testing, while useful for class A and metallo-carbapenemases,
as found to be of limited use in its ability to detect the presence
f OXA-carbapenemases. Due to the prevalence of certain OXA-
arbapenemases in Acinetobacter spp., PCR was better able to detect
hese genes. The identiﬁcation of the NDM-1 gene and other car-
apenemase genes in Jamaica underscores the need for effective
urveillance and infection controlmeasures to identify and prevent
pread of MDRGNB’s.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.611
ype: Poster Presentation
inal Abstract Number: 56.063
ession: Antibiotics
ate: Saturday, June 16, 2012
ime: 12:45-14:15
oom: Poster & Exhibition Area
ighprevalence ofD-test positivity in clinical isolates of Staphy-
ococcus aureus among Japanese children
. Toyofuku ∗, T. Tame, Y. Horikoshi
Tokyo Metropolitan Children’s Medical Center, Tokyo, Japan
Background: Clindamycin is one of options for treating skin
nd soft tissue infections caused by Staphylococcus aureus. Little
s known regarding to the prevalence of D-test positivity of clin-
cal isolates of Staphylococcus aureus among Japanese children.
ince D-test positivity is associated with treatment failure by Clin-
amycin, it is important toknowtheprevalence to select anoptimal
rst-line therapy.
Methods:We retrospectively reviewed the clinical isolates data
f Staphylococcus aureus between January 2011 and December
011 at tertiary Children’s hospital in Tokyo. Specimens were
ollected from both inpatient and outpatient. The antibiotic sus-
eptibility and D-test were performed automatically by MicroScan
alk-Away 96 Plus® (Siemens). The panel PC3.1J (Siemens) was
sed for analysis. D-test was performed according to M100-
19 Clinical Laboratory and Standards Institute (CLSI) 2009. We
eviewed the result of susceptibility and D-test of Staphylococcus
ureus isolates.
Results: The total of 468 Staphylococcus aureus was identiﬁed
n our study. The isolates collected from outpatient and inpatient
as 190 and 278, respectively. Methicillin-sensitive Staphylo-
occus aureus (MSSA) and Methicillin-resistance Staphylococcus
ureus (MRSA) were 367 (79.4%) and 101 (21.6%), respectively. D-
estwasperformedamong127MSSA isolates and44MRSA isolates.
ositive D-test rates for MSSA and MRSA were 93.7% (119/127) and
6.4% (38/44), respectively. Positive D-test rate for MRSA isolates
romoutpatient and inpatientwas 84.6% (11/13) and 87.1% (27/31),
espectively. Over all Clindamycin resistance including D-test pos-
tive strains for MSSA and MRSA was 34.1% (125/367) and 75.2%
76/101), respectively.
Conclusion: We identiﬁed high prevalence of D-test positiv-
ty both in MSSA and MRSA among Japanese children. Intravenous
ancomycin is usually the treatment of choice at inpatient. Oral
lindamycin is often preferred at outpatient. In our study, MRSA
solates from outpatient demonstrated high D-test positive rate. D-
est is not routinely performed at microbiology laboratory at small
nstitutions in Japan. Oral Clindamycinmay not be a suitable option
or MRSA treatment.
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Survey for carbapenemase-producing Klebsiella pneumoniae
isolated from clinical specimens in Thai hospitals
S. Trakulsomboon1,∗, S. Pongparit2
1 Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok,
Thailand
2 Faculty od Medical Technology,Rangsit University, Pathum Thani,
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Background: Carbapenems, broad spectrum -lactam antibi-
otics are the most effective therapy for various serious infec-
tions included those caused by Enterobacteriaceae- producing
extended spectrum -lactamases (ESBLs). The rapid spread world-
wide of carbapenem resistantKlebsiella pneumoniaeby producing
enzymes K. pneumoniae carbapenemases (KPCs) limited the
effectiveness of carbapenems in the treatment of multidrug-
resistant infections. Adequate detection of carbapenemase-
producingEnterobacteriaceaein routine diagnostic laboratory is
essential for clinical management. This study aimed to detect KPC
enzyme production in K. pneumoniae isolated from clinical speci-
mens in Thai hospitals.
Methods: A total of 351 K. pneumoniae isolates from clin-
ical specimens of 4 hospitals in Bangkokand perimeter areas
in 2010 were tested for carbapenem- resistance by ertapenem
imipenem and meropenem disk diffusion test, based on the CLSI
new breakpoint in June 2010, and Modiﬁed- Hodge test (MHT).
KPC production was conﬁrmed among the carbapenem disk non-
susceptible isolates with blaKPC gene detection by PCR.
Results: Among 351 K. pneumoniae isolates, 18 (5.13%) were
ertapenemnon-susceptible isolatesand3 isolates (0.85%)produced
MHT positive results. All ertapenem non-susceptible isolates were
blaKPC gene negative, except one isolate. The MHT positive isolate
that possessed blaKPC gene, was an MDR-ESBL producing K. pneu-
moniae recovered from respiratory tract of an infected patient. It
was highly resistant to both ertapenem and imipenem and inter-
mediate resistant to meropenem (MICs of ertapenem, imipenem
and meropenem by E-test; 8, 8 and 3 mg/L, respectively).
Conclusion: Results demonstrated the high prevalence of K.
pneumoniae resistance to carbapenems among isolates from clini-
cal specimens in Thai hospitals. The carbapenems resistant isolates
might have other resistant mechanisms than the production of
enzyme KPC. These isolates may have impact in clinical man-
agement, therefore future clinical study of infections from this
resistance organism and development for more effective assay
in routine detection of KPC are required. This study implies
that implementing guidelines for detecting carbapenem-resistant
Enterobacteriaceae are necessary for antimicrobial resistance
surveillance system inThailand. Moreover, to contain this resistant
